CIK 0001817713
- Large accelerated filer
Janux Therapeutics, Inc.
Sign in to watch- Ticker
- JANX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822289112
- Phone
- +1 858-751-4493
- Business address
- 10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 38 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-09 | Avalon Ventures XI, L.P. 10% owner | Option exercise · Stock Option (right to buy) | −414 | 12,086 | ||
| 2024-09-09 | Avalon Ventures XI, L.P. 10% owner | Option exercise · Stock Option (right to buy) | −277 | 8,073 | ||
| 2024-09-06 | Avalon Ventures XI, L.P. 10% owner | Sale | −108,365 | $42.00 | $4.6M | 3,162,851 |
| 2024-09-06 | Avalon Ventures XI, L.P. 10% owner | Sale | −20,991 | $42.00 | $882K | 612,682 |
| 2024-09-06 | Avalon Ventures XI, L.P. 10% owner | Sale | −110,644 | $42.00 | $4.6M | 3,229,374 |
| 2024-07-19 | DOBMEIER ERIC Director | Grant or award | +1,231 | 6,231 | ||
| 2024-07-19 | DOBMEIER ERIC Director | Grant or award · Stock Option (Right to Buy) | +4,111 | 4,111 | ||
| 2024-07-19 | Hernday Natasha Director | Grant or award | +1,231 | 6,231 | ||
| 2024-07-19 | Hernday Natasha Director | Grant or award · Stock Option (Right to Buy) | +4,111 | 4,111 | ||
| 2024-07-19 | DOBMEIER ERIC Director | Grant or award | +5,000 | 5,000 | ||
| 2024-07-19 | DOBMEIER ERIC Director | Grant or award | +2,500 | 7,500 | ||
| 2024-07-19 | DOBMEIER ERIC Director | Grant or award · Stock Option (Right to Buy) | +16,700 | 16,700 | ||
| 2024-07-19 | DOBMEIER ERIC Director | Grant or award · Stock Option (Right to Buy) | +8,350 | 8,350 | ||
| 2024-07-19 | Hernday Natasha Director | Grant or award | +5,000 | 5,000 | ||
| 2024-07-19 | Hernday Natasha Director | Grant or award | +2,500 | 7,500 | ||
| 2024-07-19 | Hernday Natasha Director | Grant or award · Stock Option (Right to Buy) | +16,700 | 16,700 | ||
| 2024-07-19 | Hernday Natasha Director | Grant or award · Stock Option (Right to Buy) | +8,350 | 8,350 | ||
| 2024-06-26 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award | +2,500 | 2,500 | ||
| 2024-06-26 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +8,350 | 8,350 | ||
| 2024-06-26 | Lichter Jay Director | Grant or award | +2,500 | 7,083 |
Page 12 of 15 · 294 trades